Table 3 Recipients characteristics with or without Donor Specific Antibody
| Â | Donor Specific Antibody | p-value | |
|---|---|---|---|
|  | Yes (n = 10) | No (n = 66) | |
Anti-HLA Ab (%) |  |  | < 0.001 |
 PRA ≥ 50% | 7 (70.0) | 2 (3.0) |  |
Anti-HLA Ab (MFI) |  |  | < 0.001 |
  < 1000 | 0 (0) | 45 (68.2) |  |
 1000 ≤ MFI < 3000 | 3 (30.0) | 9 (13.6) |  |
 3000 ≤ MFI < 5000 | 1 (10.0) | 6 (9.1) |  |
  ≥ 5000 | 6 (60.0) | 6 (9.1) |  |
Age, median (range), yrs | 48.5 (17–57) | 52.0 (17–75) | 0.180 |
Male, n (%) | 5 (50.0) | 37 (56.1) | 0.745 |
BMI, median (IQR), kg/m2 | 18.4 (14.3–20.0) | 19.3 (17.5–22.2) | 0.161 |
ABO, n (%) | Â | Â | 0.708 |
 A | 2 (20.0) | 24 (36.4) |  |
 B | 4 (40.0) | 22 (33.3) |  |
 AB | 1 (10.0) | 5 (7.6) |  |
 O | 3 (30.0) | 15 (22.7) |  |
Primary diagnosis, n (%) | Â | Â | 0.321 |
 COPD/emphysema | 2 (20.0) | 2 (3.0) |  |
 IPF | 3 (30.0) | 34 (51.5) |  |
 IPAH | 0 (0) | 1 (1.5) |  |
 IIP other than IPF* | 0 (0) | 3 (4.5) |  |
 Bronchiectasis/destroyed lung by TB | 0 (0) | 4 (6.1) |  |
 BOS after HSCT | 2 (20.0) | 9 (13.6) |  |
 Interstitial lung disease related with CTD | 1 (10.0) | 4 (6.1) |  |
 LAM | 2 (20.0) | 7 (10.6) |  |
 Others** | 0 (0) | 2 (3.0) |  |
Smoking, n (%) | Â | Â | 0.733 |
 Smoker | 3 (30.0) | 26 (39.4) |  |
   ≥ 20 pack-years | 3 (30.0) | 19 (28.8) |  |
   < 20 pack-years | 0 (0) | 7 (10.6) |  |
  Never smoker | 7 (70.0) | 40 (60.6) |  |
Bilateral lung transplantation, n (%) | 9 (90.0) | 53 (80.3) | 0.678 |